awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48194472-9256212B-CB0C-4D89-AF60-90BE464C4D56
Q48194472-9256212B-CB0C-4D89-AF60-90BE464C4D56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-9256212B-CB0C-4D89-AF60-90BE464C4D56
PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival.
P2860
Q48194472-9256212B-CB0C-4D89-AF60-90BE464C4D56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48194472-9256212B-CB0C-4D89-AF60-90BE464C4D56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
39083a6afc324a6ae9f8c85275df9e327b23a19c
P2860
The impact of repeated cycles of radioligand therapy using [177Lu]Lu-PSMA-617 on renal function in patients with hormone refractory metastatic prostate cancer.